Wellington Management Group LLP Akebia Therapeutics, Inc. Transaction History

Wellington Management Group LLP

$545 Billion
Q3 2025

A detailed history of Wellington Management Group LLP transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 869,804 shares of AKBA stock, worth $1.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

869,804

Previous 695,728 25.02%

Holding current value

$1.48 Million

Previous $2.53 Million 7.27%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$2.7 - $4.01 $470,005 - $698,044	174,076 Added 25.02%	869,804 $2.35 Million
Q2 2025 Aug 14, 2025	BUY	$1.55 - $3.97 $45,199 - $115,769	29,161 Added 4.37%	695,728 $2.53 Million
Q1 2025 May 13, 2025	BUY	$1.69 - $2.84 $1.13 Million - $1.89 Million	666,567 New	666,567 $1.28 Million
Q4 2024 Feb 12, 2025	BUY	$1.26 - $2.13 $122,735 - $207,481	97,409 Added 24.07%	502,127 $933,000
Q3 2024 Nov 14, 2024	BUY	$0.94 - $1.55 $380,434 - $627,312	404,718 New	404,718 $534,000

Q2 2022 Aug 15, 2022	SELL	$0.32 - $0.67 $101,396 - $212,298	-316,863 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.72 - $2.93 $2,016 - $8,206	2,801 Added 0.89%	316,863 $227,000
Q4 2021 Feb 11, 2022	BUY	$2.26 - $3.34 $709,780 - $1.05 Million	314,062 New	314,062 $710,000
Q3 2021 Nov 15, 2021	SELL	$2.35 - $3.88 $25.2 Million - $41.7 Million	-10,736,859 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.83 - $4.2 $286,695 - $425,485	-101,306 Reduced 0.93%	10,736,859 $40.7 Million
Q1 2021 May 17, 2021	SELL	$2.92 - $5.06 $5.12 Million - $8.87 Million	-1,752,298 Reduced 13.92%	10,838,165 $36.7 Million
Q4 2020 Feb 12, 2021	BUY	$2.22 - $3.78 $10.4 Million - $17.6 Million	4,665,491 Added 58.87%	12,590,463 $35.3 Million
Q3 2020 Nov 16, 2020	BUY	$2.39 - $13.08 $1.55 Million - $8.51 Million	650,249 Added 8.94%	7,924,972 $19.9 Million
Q2 2020 Aug 14, 2020	BUY	$6.67 - $13.58 $37 Million - $75.4 Million	5,549,182 Added 321.59%	7,274,723 $98.8 Million
Q1 2020 May 14, 2020	BUY	$4.1 - $10.24 $3.4 Million - $8.49 Million	828,814 Added 92.43%	1,725,541 $13.1 Million
Q4 2019 Feb 11, 2020	BUY	$3.16 - $6.73 $2.83 Million - $6.03 Million	896,727 New	896,727 $5.67 Million

Others Institutions Holding AKBA

# of Institutions

189

Shares Held

121M

Call Options Held

267K

Put Options Held

280K

View Full List

About Akebia Therapeutics, Inc.

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $313M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

More about AKBA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Akebia Therapeutics, Inc. Transaction History